Healthcare Market Research Reports
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
23 Jul 2024  |  North America  |  Technology Research
Computed Tomography Technology Innovations and Growth Opportunities
Technological Advances and Stakeholder Initiatives Enable Better Diagnostic Accuracy, Lower Radiation Exposure, and Cost Savings
Computed tomography (CT) is a sophisticated imaging technology that combines X-ray measurements obtained from multiple angles and processes them using computer algorithms to generate cross-sectional images or tomograms. The tomograms are further reconstructed into a 3D representation of organs or tissues, allowing precise visualization of the inter...
$4,950.00 -
22 Jul 2024  |  North America  |  Technology Research
Emerging Endoscopy Technologies and Growth Opportunities
Advanced Surgical Visualization and Instrumentation Innovation to Drive Transformational Growth
Emerging endoscopy technologies leverage advanced surgical visualization and instrumentation techniques during the pre-operative and intraoperative phases of surgical procedures. The use of these techniques helps surgeons to clearly visualize, accurately identify, and localize anomalies, and subsequently navigate and perform complex surgeries with ...
$4,950.00 -
24 Apr 2024  |  North America  |  Market Outlook
Global Digital Health Outlook and Growth Opportunities, 2024
The Move to Deliver Care Beyond Hospital Walls and Unique AI Use Cases will Ensure Transformational Growth
The digital health industry has maintained a consistent growth trajectory. Investing in technologies that help organizations achieve the quintuple aim of healthcare is a constant priority. However, high inflation and tight monetary policy will impact the investment landscape as it shifts from top-line growth to profitability. The use of AI tech...
$4,950.00 -
19 Dec 2022  |  North America  |  Market Outlook
Top 10 for 2023: Growth Opportunities for the Life Sciences Industry
An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...
$2,450.00
Special Price $2,082.50 save 15 %
-
14 Dec 2022  |  North America  |  Technology Research
Bionic Devices: Technology Innovations and Growth Opportunities
Disruptive Bionic Device Technologies Mimicking Natural Functioning of the Eyes, Kidneys, and Limbs
Bionic devices are mechatronic or electronic platforms that can perform the physical and biological functions of body parts or organs that are lost or damaged because of chronic conditions or accidents. Patients that suffer complete vision loss because of retinal diseases; upper and lower limb amputations caused by accidents or chronic diseases; an...
$4,950.00
Special Price $4,207.50 save 15 %
-
13 Jul 2022  |  North America  |  Tracker
Global Pharmaceutical Tracker, 2022
Digital Partnerships Focused on Drug Discovery and Development Drive Future Growth Potential
This research service offers comprehensive discussions about the key approvals, mergers and acquisitions, product licensing deals, and digital partnerships of the pharmaceutical industry in 2022. A renewed focus on operational excellence and digital transformation will push top-line pharmaceutical industry growth and drive strong partnerships with ...
$2,450.00
Special Price $1,837.50 save 25 %
-
01 Apr 2022  |  North America  |  Market Outlook
Global Medical Imaging and Informatics Outlook, 2022
Smart Manufacturing and Cloud-based AI Solutions will Drive Market Growth and the Efficiency of Medical Imaging and Informatics
The global medical imaging and informatics market is experiencing significant changes with the emergence of advanced technologies, the changing consumer landscape and priorities, consolidation among radiology practices, mergers and acquisitions, portability, regulatory and reimbursement changes, smart manufacturing, local and global manufacturing, ...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Mar 2022  |  North America  |  Market Outlook
Global Digital Health Outlook, 2022
Innovative Business Models of Remote Patient Monitoring Solutions Go beyond Chronic Care Management and Across the Care Continuum
Digital health offered extensive support and grew stronger as the pandemic continued with several variants across the globe. Telehealth and other enterprise IT solutions continued to be the backbone for healthcare systems, and access to health in the hands of the patients empowered consumers to manage their health with the best of tools. As the dem...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Mar 2022  |  North America  |  Market Outlook
Next-generation Diagnostics Outlook, 2022
Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth
In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Mar 2022  |  North America  |  Market Outlook
Global Medical Devices Outlook, 2022
Digital Efficiency Solutions for Operating Rooms and Competitive Intensity are Opening up New Growth Opportunities
As the healthcare sector adapts to the changes induced by the COVID-19 pandemic, the global medical devices industry is undergoing a major transformation in terms of business models, technology adoption, and care delivery approaches, among other areas. 2022 will prove to be another challenging year for medtech as uncertainties pertaining to COVID-1...
$4,950.00
Special Price $3,712.50 save 25 %